Skip to main
  1. Stocks
  2. Teladoc
  3. Forecast
TDOC

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 20%
Buy 13%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health is viewed positively because Integrated Care remains a steady growth engine, with chronic care momentum, healthy 2027 bookings, and management signaling that Teladoc One and recent M&A should support broader expansion. BetterHelp is also improving as its insurance pivot gains traction, with insurance revenue beating expectations, weekly covered sessions reaching 27k, and a projected exit run-rate of at least $200M in 2027 offsetting still-pressured cash-pay demand. That combination supports higher estimates to roughly $2.4B in 2026 revenue and about $303M in 2027 adjusted EBITDA, even as margin risks from advertising and scaling remain a watch point.

Bears say

Teladoc Health is facing a difficult fundamental setup as greater-than-expected pricing pressure, a challenging regulatory environment, and slower consumer adoption threaten both margins and growth. Although 3Q results beat lowered expectations and BetterHelp insurance revenue reached a $140mm annual run rate versus $110mm in 2Q, cash-pay declines are accelerating as management shifts advertising away from the cash-pay business, with 2027 ad spending expected to fall in the mid-to-high-20% range. At the same time, integrated care bookings were “generally inline,” urgent care telehealth is commoditizing, and if BetterHelp cannot convert DTC users to insurance reimbursement, the company risks losing share and failing to restore topline growth in FY27.

Teladoc (TDOC) has been analyzed by 15 analysts, with a consensus rating of Hold. 20% of analysts recommend a Strong Buy, 13% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Teladoc (TDOC) Analyst Forecast & Price Prediction

Get the latest Teladoc (TDOC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Teladoc (TDOC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Hold based on their latest research and market trends.

According to 15 analysts, Teladoc (TDOC) has a Hold consensus rating as of Nov 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Teladoc (TDOC) Analyst Forecast & Price Prediction

Get the latest Teladoc (TDOC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Teladoc (TDOC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover TDOC stock data and trends